首页 > 最新文献

Anesthesia and analgesia最新文献

英文 中文
Gender Differences in Authorship and Quality of Anesthesia Clinical Practice Guidelines From 2016 to 2020 Using the Appraisal of Guidelines for Research and Evaluation II Instrument. 使用 "研究与评估指南评估 II "工具评估 2016 至 2020 年麻醉临床实践指南作者和质量的性别差异。
IF 4.6 2区 医学 Q1 ANESTHESIOLOGY Pub Date : 2024-11-01 Epub Date: 2024-05-20 DOI: 10.1213/ANE.0000000000006803
Lisa Q Rong, Andrew P Martinez, Mohamed Rahouma, Alexandra J Lopes, Jerry Y Lee, Drew N Wright, Michelle Demetres, Bessie Kachulis, Sinead M O'Shaughnessy

Introduction: Women continue to be underrepresented in academic anesthesiology. This study assessed guidelines in anesthesia journals over the past 5 years, evaluating differences in woman-led versus man-led guidelines in terms of author gender, quality, and changes over time. We hypothesized that anesthesia guidelines would be predominately man-led, and that there would be differences in quality between woman-led versus man-led guidelines.

Methods: All clinical practice guidelines published in the top 10 anesthesia journals were identified as per Clarivate Analytics Impact Factor between 2016 and 2020. Fifty-one guidelines were included for author, gender, and quality analysis using the Appraisal of Guidelines for Research & Evaluation (AGREE) II instrument. Each guideline was assessed across 6 domains and 23 items and given an overall score, overall quality score, and overall rating/recommendation. Stratified and trend analyses were performed for woman-led versus man-led guidelines.

Results: Fifty out of 51 guidelines were included: 1 was excluded due to unidentifiable first-author gender. In total, 255 of 1052 (24%) authors were women, and woman-led guidelines (woman-first author) represented 12 of 50 (24%) overall guidelines. Eighteen percent (9 of 50) of guidelines had all-male authors, and a majority (26 of 50, 52%) had less than one-third of female authors. The overall number and percentage of woman-led guidelines did not change over time. There was a significantly higher percentage of female authors in woman-led versus man-led guidelines, median 39% vs 20% ( P = .012), as well as a significantly higher number of female coauthors in guidelines that were woman-led median 3.5 vs 1.0, P = .049. For quality, there was no significant difference in the overall rating or objective quality of woman- versus man-led guidelines. However, there was a significant increase in the overall rating of all the guidelines over time ( P = .010), driven by the increase in overall rating among man-led guidelines, P = .002. The overall score of guidelines did not increase over time; however, they increased in man-led but not woman-led guidelines. There was no significant correlation between the percentage of female authors per guideline and either overall score or overall rating.

Conclusions: There is a substantial disparity in the number of women leading and contributing to guidelines which has not improved over time. Woman-led guidelines included more women and a higher percentage of women. There was no difference in quality of guidelines by first-author gender or percentage of female authors. Further systematic and quota-driven sponsorship is needed to promote gender equity, diversity, and inclusion in anesthesia guidelines.

导言:女性在麻醉学术界的代表性仍然不足。本研究评估了过去五年中麻醉学期刊上的指南,从作者性别、质量和随时间推移的变化等方面评估了女性领导的指南与男性领导的指南之间的差异。我们假设麻醉指南主要由男性主导,而女性主导与男性主导的指南在质量上存在差异:根据 Clarivate Analytics 的影响因子,确定了 2016 年至 2020 年间在排名前 10 位的麻醉期刊上发表的所有临床实践指南。采用研究与评估指南评估(AGREE)II工具对51份指南的作者、性别和质量进行分析。对每份指南进行了 6 个领域 23 个项目的评估,并给出了总分、总体质量分和总体评分/建议。对女性领导与男性领导的指南进行了分层和趋势分析:结果:51 份指南中有 50 份被纳入:结果:51 份指南中有 50 份被纳入:1 份因无法确定第一作者性别而被排除。总计 1052 份指南中有 255 份(24%)的作者为女性,女性主导的指南(女性为第一作者)在 50 份指南中占 12 份(24%)。18%的指南(50 份中的 9 份)的作者全部为男性,大多数指南(50 份中的 26 份,52%)的女性作者比例不足三分之一。随着时间的推移,女性领导的指南总体数量和比例没有变化。女性作者在女性领导的指南中所占比例明显高于男性领导的指南,中位数分别为 39% 和 20% (P = .012),女性共同作者在女性领导的指南中所占比例也明显高于男性领导的指南,中位数分别为 3.5 和 1.0,P = .049。在质量方面,女性领导的指南与男性领导的指南在总体评分或客观质量方面没有明显差异。然而,随着时间的推移,所有指南的总体评分都有了明显的提高(P = .010),其中男性主导指南的总体评分有所提高,P = .002。指导原则的总体评分并没有随着时间的推移而增加;但是,男性主导的指导原则的总体评分有所增加,而女性主导的指导原则的总体评分则没有增加。每份指南的女性作者比例与总体得分或总体评分之间没有明显的相关性:领导和参与指南制定的女性人数差距很大,而且随着时间的推移没有改善。女性领导的指南包括更多的女性和更高比例的女性。根据第一作者的性别或女性作者的比例,指南的质量没有差异。为了促进麻醉指南中的性别平等、多样性和包容性,需要进一步开展系统性和配额驱动的赞助活动。
{"title":"Gender Differences in Authorship and Quality of Anesthesia Clinical Practice Guidelines From 2016 to 2020 Using the Appraisal of Guidelines for Research and Evaluation II Instrument.","authors":"Lisa Q Rong, Andrew P Martinez, Mohamed Rahouma, Alexandra J Lopes, Jerry Y Lee, Drew N Wright, Michelle Demetres, Bessie Kachulis, Sinead M O'Shaughnessy","doi":"10.1213/ANE.0000000000006803","DOIUrl":"10.1213/ANE.0000000000006803","url":null,"abstract":"<p><strong>Introduction: </strong>Women continue to be underrepresented in academic anesthesiology. This study assessed guidelines in anesthesia journals over the past 5 years, evaluating differences in woman-led versus man-led guidelines in terms of author gender, quality, and changes over time. We hypothesized that anesthesia guidelines would be predominately man-led, and that there would be differences in quality between woman-led versus man-led guidelines.</p><p><strong>Methods: </strong>All clinical practice guidelines published in the top 10 anesthesia journals were identified as per Clarivate Analytics Impact Factor between 2016 and 2020. Fifty-one guidelines were included for author, gender, and quality analysis using the Appraisal of Guidelines for Research & Evaluation (AGREE) II instrument. Each guideline was assessed across 6 domains and 23 items and given an overall score, overall quality score, and overall rating/recommendation. Stratified and trend analyses were performed for woman-led versus man-led guidelines.</p><p><strong>Results: </strong>Fifty out of 51 guidelines were included: 1 was excluded due to unidentifiable first-author gender. In total, 255 of 1052 (24%) authors were women, and woman-led guidelines (woman-first author) represented 12 of 50 (24%) overall guidelines. Eighteen percent (9 of 50) of guidelines had all-male authors, and a majority (26 of 50, 52%) had less than one-third of female authors. The overall number and percentage of woman-led guidelines did not change over time. There was a significantly higher percentage of female authors in woman-led versus man-led guidelines, median 39% vs 20% ( P = .012), as well as a significantly higher number of female coauthors in guidelines that were woman-led median 3.5 vs 1.0, P = .049. For quality, there was no significant difference in the overall rating or objective quality of woman- versus man-led guidelines. However, there was a significant increase in the overall rating of all the guidelines over time ( P = .010), driven by the increase in overall rating among man-led guidelines, P = .002. The overall score of guidelines did not increase over time; however, they increased in man-led but not woman-led guidelines. There was no significant correlation between the percentage of female authors per guideline and either overall score or overall rating.</p><p><strong>Conclusions: </strong>There is a substantial disparity in the number of women leading and contributing to guidelines which has not improved over time. Woman-led guidelines included more women and a higher percentage of women. There was no difference in quality of guidelines by first-author gender or percentage of female authors. Further systematic and quota-driven sponsorship is needed to promote gender equity, diversity, and inclusion in anesthesia guidelines.</p>","PeriodicalId":7784,"journal":{"name":"Anesthesia and analgesia","volume":" ","pages":"955-964"},"PeriodicalIF":4.6,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11493532/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141070419","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Propensity-Matched Cohort Study of Intravenous Iron versus Red Cell Transfusions for Preoperative Iron-Deficiency Anemia. 针对术前缺铁性贫血的静脉注射铁剂与红细胞输注的倾向匹配队列研究。
IF 4.6 2区 医学 Q1 ANESTHESIOLOGY Pub Date : 2024-11-01 Epub Date: 2024-07-22 DOI: 10.1213/ANE.0000000000006974
Una E Choi, Ryan C Nicholson, Ananda J Thomas, Elizabeth P Crowe, John A Ulatowski, Linda M S Resar, Nadia B Hensley, Steven M Frank

Background: While preoperative anemia is associated with adverse perioperative outcomes, the benefits of treatment with iron replacement versus red blood cell (RBC) transfusion remain uncertain. We used a national database to establish trends in preoperative iron-deficiency anemia (IDA) treatment and to test the hypothesis that treatment with preoperative iron may be superior to RBC transfusion.

Methods: This study is a propensity-matched retrospective cohort analysis from 2003 to 2023 using TriNetX Research Network, which included surgical patients diagnosed with IDA within 3 months preoperatively. After matching for surgery type and comorbidities, we compared a cohort of patients with preoperative IDA who were treated with preoperative intravenous (IV) iron but not RBCs (n = 77,179), with a cohort receiving preoperative RBCs but not IV iron (n = 77,179). Propensity-score matching was performed for age, ethnicity, race, sex, overweight and obesity, type 2 diabetes, hyperlipidemia, essential hypertension, heart failure, chronic ischemic heart disease, neoplasms, hypothyroidism, chronic kidney disease, nicotine dependence, surgery type, and lab values from the day of surgery including ferritin, transferrin, and hemoglobin split into low (<7 g/dL), medium (7-<12 g/dL), and high (≥12 g/dL) to account for anemia severity. The primary outcome was 30-day postoperative mortality with the secondary outcomes being 30-day morbidity, postoperative hemoglobin level, and 30-day postoperative RBC transfusion.

Results: Compared with RBC transfusion, preoperative IV iron was associated with lower risk of postoperative mortality (n = 2550/77,179 [3.3%] vs n = 4042/77,179 [5.2%]; relative risk [RR], 0.63, 95% confidence interval [CI], 0.60-0.66), and a lower risk of postoperative composite morbidity (n = 14,174/77,179 [18.4%] vs n = 18,632/77,179 [24.1%]; RR, 0.76, 95% CI, 0.75-0.78) (both P = .001 after Bonferroni adjustment). Compared with RBC transfusion, IV iron was also associated with a higher hemoglobin in the 30-day postoperative period (10.1 ± 1.8 g/dL vs 9.4 ± 1.7 g/dL, P = .001 after Bonferroni adjustment) and a reduced incidence of postoperative RBC transfusion (n = 3773/77,179 [4.9%] vs n = 12,629/77,179 [16.4%]; RR, 0.30, 95% CI, 0.29-0.31).

Conclusions: In a risk-adjusted analysis, preoperative IDA treatment with IV iron compared to RBC transfusion was associated with a reduction in 30-day postoperative mortality and morbidity, a higher 30-day postoperative hemoglobin level, and reduced postoperative RBC transfusion. This evidence represents a promising opportunity to improve patient outcomes and reduce blood transfusions and their associated risk and costs.

背景:虽然术前贫血与围手术期的不良预后有关,但补铁治疗与输注红细胞(RBC)的益处仍不确定。我们利用一个全国性数据库来确定术前缺铁性贫血(IDA)治疗的趋势,并检验术前补铁治疗可能优于输注红细胞的假设:本研究是利用 TriNetX 研究网络进行的倾向匹配回顾性队列分析,时间跨度为 2003 年至 2023 年,研究对象包括术前 3 个月内确诊为 IDA 的手术患者。在对手术类型和合并症进行匹配后,我们将术前接受静脉注射(IV)铁剂治疗但未接受 RBCs 治疗的术前 IDA 患者队列(n = 77,179 人)与术前接受 RBCs 治疗但未接受 IV 铁剂治疗的患者队列(n = 77,179 人)进行了比较。对年龄、民族、种族、性别、超重和肥胖、2 型糖尿病、高脂血症、原发性高血压、心力衰竭、慢性缺血性心脏病、肿瘤、甲状腺功能减退、慢性肾病、尼古丁依赖、手术类型以及手术当天的化验值(包括铁蛋白、转铁蛋白和血红蛋白)进行了倾向得分匹配:与输注红细胞相比,术前静脉注射铁剂与较低的术后死亡风险相关(n = 2550/77,179 [3.3%] vs n = 4042/77,179 [5.2%];相对风险 [RR],0.63,95% 置信区间 [CI],0.60-0.66),术后综合发病率风险较低(n = 14,174/77,179 [18.4%] vs n = 18,632/77,179 [24.1%];RR,0.76,95% CI,0.75-0.78)(经 Bonferroni 调整后,P 均 = .001)。与输注红细胞相比,静脉注射铁剂还能提高术后 30 天的血红蛋白(10.1 ± 1.8 g/dL vs 9.4 ± 1.7 g/dL,经 Bonferroni 调整后 P = .001),降低术后输注红细胞的发生率(n = 3773/77179 [4.9%] vs n = 12629/77179 [16.4%];RR,0.30,95% CI,0.29-0.31):在风险调整分析中,术前静脉注射铁剂治疗 IDA 与输注红细胞相比,术后 30 天死亡率和发病率降低,术后 30 天血红蛋白水平提高,术后输注红细胞减少。这一证据为改善患者预后、减少输血及其相关风险和费用提供了一个很好的机会。
{"title":"A Propensity-Matched Cohort Study of Intravenous Iron versus Red Cell Transfusions for Preoperative Iron-Deficiency Anemia.","authors":"Una E Choi, Ryan C Nicholson, Ananda J Thomas, Elizabeth P Crowe, John A Ulatowski, Linda M S Resar, Nadia B Hensley, Steven M Frank","doi":"10.1213/ANE.0000000000006974","DOIUrl":"10.1213/ANE.0000000000006974","url":null,"abstract":"<p><strong>Background: </strong>While preoperative anemia is associated with adverse perioperative outcomes, the benefits of treatment with iron replacement versus red blood cell (RBC) transfusion remain uncertain. We used a national database to establish trends in preoperative iron-deficiency anemia (IDA) treatment and to test the hypothesis that treatment with preoperative iron may be superior to RBC transfusion.</p><p><strong>Methods: </strong>This study is a propensity-matched retrospective cohort analysis from 2003 to 2023 using TriNetX Research Network, which included surgical patients diagnosed with IDA within 3 months preoperatively. After matching for surgery type and comorbidities, we compared a cohort of patients with preoperative IDA who were treated with preoperative intravenous (IV) iron but not RBCs (n = 77,179), with a cohort receiving preoperative RBCs but not IV iron (n = 77,179). Propensity-score matching was performed for age, ethnicity, race, sex, overweight and obesity, type 2 diabetes, hyperlipidemia, essential hypertension, heart failure, chronic ischemic heart disease, neoplasms, hypothyroidism, chronic kidney disease, nicotine dependence, surgery type, and lab values from the day of surgery including ferritin, transferrin, and hemoglobin split into low (<7 g/dL), medium (7-<12 g/dL), and high (≥12 g/dL) to account for anemia severity. The primary outcome was 30-day postoperative mortality with the secondary outcomes being 30-day morbidity, postoperative hemoglobin level, and 30-day postoperative RBC transfusion.</p><p><strong>Results: </strong>Compared with RBC transfusion, preoperative IV iron was associated with lower risk of postoperative mortality (n = 2550/77,179 [3.3%] vs n = 4042/77,179 [5.2%]; relative risk [RR], 0.63, 95% confidence interval [CI], 0.60-0.66), and a lower risk of postoperative composite morbidity (n = 14,174/77,179 [18.4%] vs n = 18,632/77,179 [24.1%]; RR, 0.76, 95% CI, 0.75-0.78) (both P = .001 after Bonferroni adjustment). Compared with RBC transfusion, IV iron was also associated with a higher hemoglobin in the 30-day postoperative period (10.1 ± 1.8 g/dL vs 9.4 ± 1.7 g/dL, P = .001 after Bonferroni adjustment) and a reduced incidence of postoperative RBC transfusion (n = 3773/77,179 [4.9%] vs n = 12,629/77,179 [16.4%]; RR, 0.30, 95% CI, 0.29-0.31).</p><p><strong>Conclusions: </strong>In a risk-adjusted analysis, preoperative IDA treatment with IV iron compared to RBC transfusion was associated with a reduction in 30-day postoperative mortality and morbidity, a higher 30-day postoperative hemoglobin level, and reduced postoperative RBC transfusion. This evidence represents a promising opportunity to improve patient outcomes and reduce blood transfusions and their associated risk and costs.</p>","PeriodicalId":7784,"journal":{"name":"Anesthesia and analgesia","volume":" ","pages":"969-977"},"PeriodicalIF":4.6,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141747206","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Gadolinium-Based Contrast Agents: Rationale for Use in Patients with Iodine Contrast or Shellfish Allergy? 钆基造影剂:碘造影剂或贝类过敏患者的使用理由?
IF 4.6 2区 医学 Q1 ANESTHESIOLOGY Pub Date : 2024-11-01 Epub Date: 2024-06-04 DOI: 10.1213/ANE.0000000000006976
Parker R M Kenee, Mark S Zimmer, Rohit R Kamath, Sumin Son, Christian H Gulde, Jarrett R Campbell, Syed S Jaffery, Biral T Patel
{"title":"Gadolinium-Based Contrast Agents: Rationale for Use in Patients with Iodine Contrast or Shellfish Allergy?","authors":"Parker R M Kenee, Mark S Zimmer, Rohit R Kamath, Sumin Son, Christian H Gulde, Jarrett R Campbell, Syed S Jaffery, Biral T Patel","doi":"10.1213/ANE.0000000000006976","DOIUrl":"10.1213/ANE.0000000000006976","url":null,"abstract":"","PeriodicalId":7784,"journal":{"name":"Anesthesia and analgesia","volume":" ","pages":"1097-1100"},"PeriodicalIF":4.6,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141247169","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
In Response. 回应:
IF 4.6 2区 医学 Q1 ANESTHESIOLOGY Pub Date : 2024-11-01 Epub Date: 2024-10-21 DOI: 10.1213/ANE.0000000000007139
Akinori Maeda, Rinaldo Bellomo
{"title":"In Response.","authors":"Akinori Maeda, Rinaldo Bellomo","doi":"10.1213/ANE.0000000000007139","DOIUrl":"https://doi.org/10.1213/ANE.0000000000007139","url":null,"abstract":"","PeriodicalId":7784,"journal":{"name":"Anesthesia and analgesia","volume":"139 5","pages":"e54-e55"},"PeriodicalIF":4.6,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142456251","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Association of Guideline-Directed Prophylaxis With Postoperative Nausea and Vomiting in Adult Patients: A Single-Center, Retrospective Cohort Study. 指南指导的预防措施与成人患者术后恶心和呕吐的关系:单中心回顾性队列研究
IF 4.6 2区 医学 Q1 ANESTHESIOLOGY Pub Date : 2024-11-01 Epub Date: 2024-01-31 DOI: 10.1213/ANE.0000000000006855
Benjamin Y Andrew, Romel Holmes, Brad M Taicher, Ashraf S Habib
<p><strong>Background: </strong>Consensus guidelines for postoperative nausea and vomiting (PONV) prophylaxis recommend a risk-based approach in which the number of antiemetics administered is based on a preoperative estimate of PONV risk. These guidelines have been adapted by the Multicenter Perioperative Outcomes Group (MPOG) to serve as measures of clinician and hospital compliance with guideline-recommended care. However, the impact of this approach on clinical outcomes is not known.</p><p><strong>Methods: </strong>We performed a single-center, retrospective study of adult patients undergoing general anesthesia from 2018 to 2021. Risk factors for PONV were defined using MPOG definitions: female sex, history of PONV or motion sickness, nonsmoker, inhaled anesthesia >60 minutes, high-risk procedure (cholecystectomy, laparoscopic, gynecologic), and age <50 years. Adequate prophylaxis was defined using the MPOG PONV-05 metric: at least 2 agents for patients with 1 to 2 risk factors and at least 3 agents for patients with 3+ risk factors. PONV was defined as documented PONV or receipt of rescue antiemetics. To estimate the association between adequate prophylaxis and PONV, we used Bayesian binomial models with overlap propensity score weighting.</p><p><strong>Results: </strong>We included 76,703 cases (43% receiving adequate prophylaxis) with PONV occurring in 19%. In unadjusted and unweighted comparison, adequate prophylaxis was associated with increased incidence of PONV: median odds ratio 1.21 (95% credible interval [1.16-1.25]). However, after propensity score weighting and multivariable adjustment, adequate prophylaxis was associated with reduced relative and absolute risk for PONV: weighted marginal median odds ratio 0.90 [0.84-0.98] and absolute risk reduction (ARR) 1.6% [0.6%-2.6%]. There was evidence for a differential effect of adequate prophylaxis across the guideline-defined risk spectrum, with benefit seen in patients with 1 to 5 risk factors (conditional probabilities of benefit >0.81), but not in those at high predicted risk. Patient-specific, covariate-adjusted ARR was heterogeneous, with a median patient-specific conditional probability of benefit of 0.84 (95% credible interval, 0.73-0.90).</p><p><strong>Conclusions: </strong>Guideline-directed PONV prophylaxis is associated with a modest reduction in PONV, although this effect is small and heterogeneous on the absolute scale. We found evidence for a differential association between adequate prophylaxis and PONV across the guideline-defined risk spectrum, with diminution in patients at very high predicted preoperative risk. While patient-specific benefit was heterogenous, most patients had reasonably high predicted probabilities of absolute benefit from a guideline-directed strategy. Further assessment of these associations in a multicenter setting, with more robust investigation of risk prediction methods will allow for better understanding of the optimal approach to PONV prophyl
背景:术后恶心呕吐(PONV)预防共识指南建议采用基于风险的方法,即根据术前对 PONV 风险的估计来确定止吐药的用量。多中心围手术期结果小组(MPOG)对这些指南进行了调整,以作为衡量临床医生和医院是否遵守指南推荐护理的标准。然而,这种方法对临床结果的影响尚不清楚:我们对 2018 年至 2021 年接受全身麻醉的成年患者进行了一项单中心回顾性研究。采用 MPOG 定义定义了 PONV 的风险因素:女性性别、PONV 或晕动病史、不吸烟、吸入麻醉时间大于 60 分钟、高风险手术(胆囊切除术、腹腔镜手术、妇科手术)和年龄 结果:我们纳入了 76703 个病例(43% 接受了充分的预防措施),其中 19% 出现了 PONV。在未调整和未加权比较中,充分预防与 PONV 发生率的增加有关:中位几率比 1.21(95% 可信区间 [1.16-1.25])。然而,经过倾向评分加权和多变量调整后,充分预防与 PONV 相对风险和绝对风险的降低有关:加权边际中位几率为 0.90 [0.84-0.98],绝对风险降低率 (ARR) 为 1.6% [0.6%-2.6%]。有证据表明,在指南定义的风险范围内,适当的预防措施具有不同的效果,具有 1 至 5 个风险因素的患者可获益(获益的条件概率大于 0.81),但预测风险较高的患者则不能获益。患者特异性、协变量调整后的获益概率存在差异,患者特异性获益条件概率中位数为0.84(95%可信区间为0.73-0.90):指南指导下的 PONV 预防与 PONV 的适度减少有关,尽管这种效应很小,而且在绝对规模上存在差异。我们发现有证据表明,在指南定义的风险范围内,充分的预防措施与 PONV 之间存在不同的关联,术前预测风险极高的患者的 PONV 会降低。虽然患者的特异性获益不尽相同,但大多数患者从指南指导的策略中获得绝对获益的预测概率相当高。在多中心环境中进一步评估这些关联,并对风险预测方法进行更有力的研究,将有助于更好地了解预防 PONV 的最佳方法。
{"title":"The Association of Guideline-Directed Prophylaxis With Postoperative Nausea and Vomiting in Adult Patients: A Single-Center, Retrospective Cohort Study.","authors":"Benjamin Y Andrew, Romel Holmes, Brad M Taicher, Ashraf S Habib","doi":"10.1213/ANE.0000000000006855","DOIUrl":"10.1213/ANE.0000000000006855","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Background: &lt;/strong&gt;Consensus guidelines for postoperative nausea and vomiting (PONV) prophylaxis recommend a risk-based approach in which the number of antiemetics administered is based on a preoperative estimate of PONV risk. These guidelines have been adapted by the Multicenter Perioperative Outcomes Group (MPOG) to serve as measures of clinician and hospital compliance with guideline-recommended care. However, the impact of this approach on clinical outcomes is not known.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Methods: &lt;/strong&gt;We performed a single-center, retrospective study of adult patients undergoing general anesthesia from 2018 to 2021. Risk factors for PONV were defined using MPOG definitions: female sex, history of PONV or motion sickness, nonsmoker, inhaled anesthesia &gt;60 minutes, high-risk procedure (cholecystectomy, laparoscopic, gynecologic), and age &lt;50 years. Adequate prophylaxis was defined using the MPOG PONV-05 metric: at least 2 agents for patients with 1 to 2 risk factors and at least 3 agents for patients with 3+ risk factors. PONV was defined as documented PONV or receipt of rescue antiemetics. To estimate the association between adequate prophylaxis and PONV, we used Bayesian binomial models with overlap propensity score weighting.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;We included 76,703 cases (43% receiving adequate prophylaxis) with PONV occurring in 19%. In unadjusted and unweighted comparison, adequate prophylaxis was associated with increased incidence of PONV: median odds ratio 1.21 (95% credible interval [1.16-1.25]). However, after propensity score weighting and multivariable adjustment, adequate prophylaxis was associated with reduced relative and absolute risk for PONV: weighted marginal median odds ratio 0.90 [0.84-0.98] and absolute risk reduction (ARR) 1.6% [0.6%-2.6%]. There was evidence for a differential effect of adequate prophylaxis across the guideline-defined risk spectrum, with benefit seen in patients with 1 to 5 risk factors (conditional probabilities of benefit &gt;0.81), but not in those at high predicted risk. Patient-specific, covariate-adjusted ARR was heterogeneous, with a median patient-specific conditional probability of benefit of 0.84 (95% credible interval, 0.73-0.90).&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Conclusions: &lt;/strong&gt;Guideline-directed PONV prophylaxis is associated with a modest reduction in PONV, although this effect is small and heterogeneous on the absolute scale. We found evidence for a differential association between adequate prophylaxis and PONV across the guideline-defined risk spectrum, with diminution in patients at very high predicted preoperative risk. While patient-specific benefit was heterogenous, most patients had reasonably high predicted probabilities of absolute benefit from a guideline-directed strategy. Further assessment of these associations in a multicenter setting, with more robust investigation of risk prediction methods will allow for better understanding of the optimal approach to PONV prophyl","PeriodicalId":7784,"journal":{"name":"Anesthesia and analgesia","volume":" ","pages":"1006-1016"},"PeriodicalIF":4.6,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139650128","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Not Even a Whisper: On Losing One's Voice. 悄无声息关于失声。
IF 4.6 2区 医学 Q1 ANESTHESIOLOGY Pub Date : 2024-11-01 Epub Date: 2024-03-12 DOI: 10.1213/ANE.0000000000006818
Alan M Smeltz
{"title":"Not Even a Whisper: On Losing One's Voice.","authors":"Alan M Smeltz","doi":"10.1213/ANE.0000000000006818","DOIUrl":"10.1213/ANE.0000000000006818","url":null,"abstract":"","PeriodicalId":7784,"journal":{"name":"Anesthesia and analgesia","volume":" ","pages":"1125-1126"},"PeriodicalIF":4.6,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140058549","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Sevoflurane Postconditioning Protects From an Early Neurological Deficit After Subarachnoid Hemorrhage: Results of a Randomized Laboratory Study in Rats. 七氟醚后处理保护蛛网膜下腔出血后的早期神经功能缺损:大鼠随机实验室研究结果。
IF 4.6 2区 医学 Q1 ANESTHESIOLOGY Pub Date : 2024-11-01 Epub Date: 2024-10-21 DOI: 10.1213/ANE.0000000000006829
Laurent Morax, Beatrice Beck-Schimmer, Jonah Neff, Mattia Mueller, Renata Flury-Frei, Martin Schläpfer

Background: Subarachnoid hemorrhage (SAH) is associated with neurocognitive impairment. Recent data suggest that sevoflurane attenuates edema formation after SAH in rats. However, so far, no information is available about the long-term repair phase, nor if sevoflurane impacts functionality by increasing vascularity. This study tested whether sevoflurane postconditioning would improve long-term neurologic deficit through increased formation of new vessels close to the hemorrhage area.

Methods: Fifty-three animals were subjected to SAH or sham surgery with or without a 2-hour sevoflurane postconditioning (versus propofol anesthesia). Animal survival, including dropout animals due to death or reaching termination criteria, as well as neurologic deficit, defined by the Garcia score, were assessed 2 hours after recovery until postoperative day 14. On day 14, blood samples and brain tissue were harvested. Vessel density was determined by the number of cluster of differentiation 31 (CD31)-positive vessels, and activated glial cells by glial fibrillary acidic protein (GFAP)-positive astrocytes per field of view.

Results: The survival rate for sham animals was 100%, 69% in the SAH-propofol and 92% in the SAH-sevoflurane groups. According to the log-rank Mantel-Cox test, survival curves were significantly different ( P = .024). The short-term neurologic deficit was higher in SAH-propofol versus SAH-sevoflurane animals 2 hours after recovery and on postoperative day 1 (propofol versus sevoflurane: 14. 6 ± 3.4 vs 15. 9 ± 2.7 points, P = .034, and 16. 2 ± 3.5 vs 17. 8 ± 0.9 points, P = .015). Overall complete recovery from neurologic deficit was observed on day 7 in both SAH groups (18. 0 ± 0.0 vs 18. 0 ± 0.0 points, P = 1.000). Cortical vascular density increased to 80. 6 ± 15.0 vessels per field of view in SAH-propofol animals (vs 71. 4 ± 10.1 in SAH-sevoflurane, P < .001). Activation of glial cells, an indicator of neuroinflammation, was assessed by GFAP-positive astrocytes GFAP per field of view. Hippocampal GFAP-positive cells were 201 ± 68 vs 179 ± 84 cells per field of view in SAH-propofol versus SAH-sevoflurane animals ( P < .001).

Conclusions: Sevoflurane postconditioning improves survival by 23% (SAH-sevoflurane versus SAH-propofol). The sevoflurane intervention could attenuate the early neurologic deficit, while the long-term outcome was similar across the groups. A higher vascular density close to the SAH area in the propofol group was not associated with improved outcomes.

背景:蛛网膜下腔出血(SAH蛛网膜下腔出血(SAH)与神经认知障碍有关。最新数据表明,七氟烷可减轻大鼠蛛网膜下腔出血后水肿的形成。然而,到目前为止,还没有关于长期修复阶段的信息,也没有关于七氟烷是否会通过增加血管来影响功能的信息。本研究测试了七氟烷后处理是否会通过增加出血区域附近新血管的形成来改善长期神经功能缺损:方法:53 只动物接受了 SAH 或假手术,并接受或不接受 2 小时的七氟醚后处理(与异丙酚麻醉相比)。动物存活率(包括因死亡或达到终止标准而辍学的动物)以及神经功能缺损(以加西亚评分定义)在恢复后2小时至术后第14天进行评估。术后第 14 天,采集血液样本和脑组织。血管密度根据每视野中分化簇 31(CD31)阳性血管的数量确定,活化胶质细胞根据胶质纤维酸性蛋白(GFAP)阳性星形胶质细胞的数量确定:假动物存活率为100%,SAH-丙泊酚组为69%,SAH-七氟醚组为92%。根据对数秩曼特尔-考克斯检验,存活率曲线存在显著差异(P = .024)。恢复后2小时和术后第1天,SAH-丙泊酚组动物的短期神经功能缺损高于SAH-七氟醚组动物(丙泊酚组与七氟醚组:14.9 ± 2.7 分,P = 0.034,以及 16.2 ± 3.5 vs 17.8 ± 0.9 分,P = .015)。两组 SAH 患者在第 7 天均观察到神经功能缺损完全恢复(18.0 ± 0.0 vs 18. 0 ± 0.0 分,P = 1.000)。皮质血管密度增至每视野 80.6 ± 15.0(SAH-丙泊酚组为 71. 4 ± 10.1,P < .001)。神经胶质细胞的活化是神经炎症的一个指标,通过每个视野中 GFAP 阳性的星形胶质细胞 GFAP 进行评估。在SAH-丙泊酚与SAH-七氟醚动物中,海马GFAP阳性细胞为每视野201 ± 68个与179 ± 84个(P < .001):结论:七氟烷后处理可将存活率提高23%(SAH-七氟烷与SAH-丙泊酚相比)。七氟醚干预可减轻早期神经功能缺损,而各组的长期结果相似。丙泊酚组SAH区域附近的血管密度较高,但这与预后的改善无关。
{"title":"Sevoflurane Postconditioning Protects From an Early Neurological Deficit After Subarachnoid Hemorrhage: Results of a Randomized Laboratory Study in Rats.","authors":"Laurent Morax, Beatrice Beck-Schimmer, Jonah Neff, Mattia Mueller, Renata Flury-Frei, Martin Schläpfer","doi":"10.1213/ANE.0000000000006829","DOIUrl":"10.1213/ANE.0000000000006829","url":null,"abstract":"<p><strong>Background: </strong>Subarachnoid hemorrhage (SAH) is associated with neurocognitive impairment. Recent data suggest that sevoflurane attenuates edema formation after SAH in rats. However, so far, no information is available about the long-term repair phase, nor if sevoflurane impacts functionality by increasing vascularity. This study tested whether sevoflurane postconditioning would improve long-term neurologic deficit through increased formation of new vessels close to the hemorrhage area.</p><p><strong>Methods: </strong>Fifty-three animals were subjected to SAH or sham surgery with or without a 2-hour sevoflurane postconditioning (versus propofol anesthesia). Animal survival, including dropout animals due to death or reaching termination criteria, as well as neurologic deficit, defined by the Garcia score, were assessed 2 hours after recovery until postoperative day 14. On day 14, blood samples and brain tissue were harvested. Vessel density was determined by the number of cluster of differentiation 31 (CD31)-positive vessels, and activated glial cells by glial fibrillary acidic protein (GFAP)-positive astrocytes per field of view.</p><p><strong>Results: </strong>The survival rate for sham animals was 100%, 69% in the SAH-propofol and 92% in the SAH-sevoflurane groups. According to the log-rank Mantel-Cox test, survival curves were significantly different ( P = .024). The short-term neurologic deficit was higher in SAH-propofol versus SAH-sevoflurane animals 2 hours after recovery and on postoperative day 1 (propofol versus sevoflurane: 14. 6 ± 3.4 vs 15. 9 ± 2.7 points, P = .034, and 16. 2 ± 3.5 vs 17. 8 ± 0.9 points, P = .015). Overall complete recovery from neurologic deficit was observed on day 7 in both SAH groups (18. 0 ± 0.0 vs 18. 0 ± 0.0 points, P = 1.000). Cortical vascular density increased to 80. 6 ± 15.0 vessels per field of view in SAH-propofol animals (vs 71. 4 ± 10.1 in SAH-sevoflurane, P < .001). Activation of glial cells, an indicator of neuroinflammation, was assessed by GFAP-positive astrocytes GFAP per field of view. Hippocampal GFAP-positive cells were 201 ± 68 vs 179 ± 84 cells per field of view in SAH-propofol versus SAH-sevoflurane animals ( P < .001).</p><p><strong>Conclusions: </strong>Sevoflurane postconditioning improves survival by 23% (SAH-sevoflurane versus SAH-propofol). The sevoflurane intervention could attenuate the early neurologic deficit, while the long-term outcome was similar across the groups. A higher vascular density close to the SAH area in the propofol group was not associated with improved outcomes.</p>","PeriodicalId":7784,"journal":{"name":"Anesthesia and analgesia","volume":"139 5","pages":"1075-1085"},"PeriodicalIF":4.6,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142493126","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Prospective Observational Cohort Study of Language Preference and Preoperative Cognitive Screening in Older Adults: Do Language Disparities Exist in Cognitive Screening and Does the Association Between Test Results and Postoperative Delirium Differ Based on Language Preference? 语言偏好与老年人术前认知筛查的前瞻性观察队列研究:认知筛查中是否存在语言差异,测试结果与术后谵妄之间的关联是否因语言偏好而异?
IF 4.6 2区 医学 Q1 ANESTHESIOLOGY Pub Date : 2024-11-01 Epub Date: 2024-02-07 DOI: 10.1213/ANE.0000000000006780
Cecilia Canales, Cecilia M Ramirez, Shangyang C Yang, Sharon A Feinberg, Tristan R Grogan, Robert A Whittington, Catherine Sarkisian, Maxime Cannesson

Background: A greater percentage of surgical procedures are being performed each year on patients 65 years of age or older. Concurrently, a growing proportion of patients in English-speaking countries such as the United States, United Kingdom, Australia, and Canada have a language other than English (LOE) preference. We aimed to measure whether patients with LOE underwent cognitive screening at the same rates as their English-speaking counterparts when routine screening was instituted. We also aimed to measure the association between preoperative Mini-Cog and postoperative delirium (POD) in both English-speaking and LOE patients.

Methods: We conducted a single-center, observational cohort study in patients 65 years old or older, scheduled for surgery and evaluated in the preoperative clinic. Cognitive screening of older adults was recommended as an institutional program for all patients 65 and older presenting to the preoperative clinic. We measured program adherence for cognitive screening. We also assessed the association of preoperative impairment on Mini-Cog and POD in both English-speaking and LOE patients, and whether the association differed for the 2 groups. A Mini-Cog score ≤2 was considered impaired. Postoperatively, patients were assessed for POD using the Confusion Assessment Method (CAM) and by systematic chart review.

Results: Over a 3-year period (February 2019-January 2022), 2446 patients 65 years old or older were assessed in the preoperative clinic prior. Of those 1956 patients underwent cognitive screening. Eighty-nine percent of English-speaking patients underwent preoperative cognitive screening, compared to 58% of LOE patients. The odds of having a Mini-Cog assessment were 5.6 times higher (95% confidence interval [CI], 4.6-7.0) P < .001 for English-speaking patients compared to LOE patients. In English-speaking patients with a positive Mini-Cog screen, the odds of having postop delirium were 3.5 times higher (95% CI, 2.6-4.8) P < .001 when compared to negative Mini-Cog. In LOE patients, the odds of having postop delirium were 3.9 times higher (95% CI, 2.1-7.3) P < .001 for those with a positive Mini-Cog compared to a negative Mini-Cog. The difference between these 2 odds ratios was not significant ( P = .753).

Conclusions: We observed a disparity in the rates LOE patients were cognitively screened before surgery, despite the Mini-Cog being associated with POD in both English-speaking and LOE patients. Efforts should be made to identify barriers to cognitive screening in limited English-proficient older adults.

背景:每年都有越来越多的外科手术是为 65 岁或以上的患者实施的。与此同时,在美国、英国、澳大利亚和加拿大等英语国家,越来越多的患者偏好英语以外的语言(LOE)。我们的目的是测量在开展常规筛查时,使用非英语语言(LOE)的患者接受认知筛查的比例是否与使用英语的患者相同。我们还旨在测量讲英语和讲 LOE 患者术前 Mini-Cog 与术后谵妄(POD)之间的关联:我们对 65 岁或以上、计划接受手术并在术前门诊接受评估的患者进行了一项单中心观察性队列研究。我们建议将老年人认知筛查作为一项机构计划,适用于所有前来术前门诊就诊的 65 岁及以上患者。我们测量了认知筛查计划的执行情况。我们还评估了讲英语的患者和讲俄语的患者术前认知障碍与 Mini-Cog 和 POD 的关系,以及这两组患者术前认知障碍与 POD 的关系是否存在差异。Mini-Cog 评分≤2 分被视为智力受损。术后,采用混淆评估法(CAM)和系统性病历审查对患者进行POD评估:在 3 年内(2019 年 2 月至 2022 年 1 月),共有 2446 名 65 岁或以上的患者在术前门诊接受了评估。其中 1956 名患者接受了认知筛查。89%的英语患者接受了术前认知筛查,而 LOE 患者的这一比例为 58%。与 LOE 患者相比,讲英语的患者接受 Mini-Cog 评估的几率要高出 5.6 倍(95% 置信区间 [CI],4.6-7.0),P < .001。在 Mini-Cog 筛查呈阳性的英语患者中,与 Mini-Cog 筛查呈阴性的患者相比,术后出现谵妄的几率高出 3.5 倍(95% 置信区间 [CI],2.6-4.8),P < .001。在LOE患者中,Mini-Cog阳性与Mini-Cog阴性相比,术后出现谵妄的几率高出3.9倍(95% CI,2.1-7.3),P < .001。这两个几率之间的差异不显著(P = .753):我们观察到,尽管Mini-Cog与英语患者和LOE患者的POD相关,但LOE患者在术前接受认知筛查的比例存在差异。应努力找出英语水平有限的老年人进行认知筛查的障碍。
{"title":"A Prospective Observational Cohort Study of Language Preference and Preoperative Cognitive Screening in Older Adults: Do Language Disparities Exist in Cognitive Screening and Does the Association Between Test Results and Postoperative Delirium Differ Based on Language Preference?","authors":"Cecilia Canales, Cecilia M Ramirez, Shangyang C Yang, Sharon A Feinberg, Tristan R Grogan, Robert A Whittington, Catherine Sarkisian, Maxime Cannesson","doi":"10.1213/ANE.0000000000006780","DOIUrl":"10.1213/ANE.0000000000006780","url":null,"abstract":"<p><strong>Background: </strong>A greater percentage of surgical procedures are being performed each year on patients 65 years of age or older. Concurrently, a growing proportion of patients in English-speaking countries such as the United States, United Kingdom, Australia, and Canada have a language other than English (LOE) preference. We aimed to measure whether patients with LOE underwent cognitive screening at the same rates as their English-speaking counterparts when routine screening was instituted. We also aimed to measure the association between preoperative Mini-Cog and postoperative delirium (POD) in both English-speaking and LOE patients.</p><p><strong>Methods: </strong>We conducted a single-center, observational cohort study in patients 65 years old or older, scheduled for surgery and evaluated in the preoperative clinic. Cognitive screening of older adults was recommended as an institutional program for all patients 65 and older presenting to the preoperative clinic. We measured program adherence for cognitive screening. We also assessed the association of preoperative impairment on Mini-Cog and POD in both English-speaking and LOE patients, and whether the association differed for the 2 groups. A Mini-Cog score ≤2 was considered impaired. Postoperatively, patients were assessed for POD using the Confusion Assessment Method (CAM) and by systematic chart review.</p><p><strong>Results: </strong>Over a 3-year period (February 2019-January 2022), 2446 patients 65 years old or older were assessed in the preoperative clinic prior. Of those 1956 patients underwent cognitive screening. Eighty-nine percent of English-speaking patients underwent preoperative cognitive screening, compared to 58% of LOE patients. The odds of having a Mini-Cog assessment were 5.6 times higher (95% confidence interval [CI], 4.6-7.0) P < .001 for English-speaking patients compared to LOE patients. In English-speaking patients with a positive Mini-Cog screen, the odds of having postop delirium were 3.5 times higher (95% CI, 2.6-4.8) P < .001 when compared to negative Mini-Cog. In LOE patients, the odds of having postop delirium were 3.9 times higher (95% CI, 2.1-7.3) P < .001 for those with a positive Mini-Cog compared to a negative Mini-Cog. The difference between these 2 odds ratios was not significant ( P = .753).</p><p><strong>Conclusions: </strong>We observed a disparity in the rates LOE patients were cognitively screened before surgery, despite the Mini-Cog being associated with POD in both English-speaking and LOE patients. Efforts should be made to identify barriers to cognitive screening in limited English-proficient older adults.</p>","PeriodicalId":7784,"journal":{"name":"Anesthesia and analgesia","volume":" ","pages":"903-911"},"PeriodicalIF":4.6,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11303592/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139696814","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluation of a Novel Adjunct to Facilitate Tracheal Intubation. 评估用于气管插管的新型辅助工具
IF 4.6 2区 医学 Q1 ANESTHESIOLOGY Pub Date : 2024-11-01 Epub Date: 2024-06-24 DOI: 10.1213/ANE.0000000000007040
Roxaneh Zarnegar, Irving Caplan, Giovani Fossati, Rui Loureiro
{"title":"Evaluation of a Novel Adjunct to Facilitate Tracheal Intubation.","authors":"Roxaneh Zarnegar, Irving Caplan, Giovani Fossati, Rui Loureiro","doi":"10.1213/ANE.0000000000007040","DOIUrl":"10.1213/ANE.0000000000007040","url":null,"abstract":"","PeriodicalId":7784,"journal":{"name":"Anesthesia and analgesia","volume":" ","pages":"1119-1121"},"PeriodicalIF":4.6,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11465797/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141445214","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comments on "Expert Opinion on Anesthetic Considerations For Patients Receiving a Classic Monoamine Oxidase Inhibitor". 关于 "接受经典单胺氧化酶抑制剂的患者的麻醉考虑因素专家意见 "的评论。
IF 4.6 2区 医学 Q1 ANESTHESIOLOGY Pub Date : 2024-11-01 Epub Date: 2024-10-21 DOI: 10.1213/ANE.0000000000007145
Dorothea Hall
{"title":"Comments on \"Expert Opinion on Anesthetic Considerations For Patients Receiving a Classic Monoamine Oxidase Inhibitor\".","authors":"Dorothea Hall","doi":"10.1213/ANE.0000000000007145","DOIUrl":"https://doi.org/10.1213/ANE.0000000000007145","url":null,"abstract":"","PeriodicalId":7784,"journal":{"name":"Anesthesia and analgesia","volume":"139 5","pages":"e55-e56"},"PeriodicalIF":4.6,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142456249","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Anesthesia and analgesia
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1